Consumption · adults and children
1 finding from 1 review
Annual increment in DMFS (D3) · Children and adolescents with permanent dentition
Not adjusted meta-regression beta was 0.43 per additional follow-up year.
4 findings from 1 review
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Not adjusted
Meta-regression beta per year of follow-up 0.43 [0.04, 0.83]
22 studies · 11300 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings and age at baseline
Meta-regression beta per year of follow-up 0.64 [0.31, 0.96]
22 studies · 11300 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings age at baseline and baseline caries experience
Meta-regression beta per year of follow-up 0.37 [0.04, 0.70]
22 studies · 11300 participants
GRADE not reported
Show 1 more finding
Annual increment in DMFT (D3) · Children and adolescents with permanent dentition
Not adjusted meta-regression beta was 0.18 per additional follow-up year.
3 findings from 1 review
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Not adjusted
Meta-regression beta per year of follow-up 0.18 [-0.04, 0.40]
13 studies · 24753 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings and age at baseline
Meta-regression beta per year of follow-up 0.18 [0.02, 0.35]
13 studies · 24753 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings age at baseline and baseline caries experience
Meta-regression beta per year of follow-up 0.23 [0.06, 0.40]
13 studies · 24753 participants
GRADE not reported
Caries incidence rate per person-year at risk (D3) · Children and adolescents with permanent dentition
Adjusted for groups 1-4 including relevance of evidence and risk of bias meta-regression beta was -0.02 per additional follow-up year.
5 findings from 1 review
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for groups 1-4 including relevance of evidence and risk of bias
Meta-regression beta per year of follow-up -0.02 [-0.05, 0.01]
15 studies · 10768 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings age at baseline and baseline caries experience
Meta-regression beta per year of follow-up 0.00 [-0.00, 0.01]
15 studies · 10768 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for bitewings and age at baseline
Meta-regression beta per year of follow-up 0.00 [-0.00, 0.01]
15 studies · 10768 participants
GRADE not reported
Show 2 more findings
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Adjusted for groups 1-3 including decade and preventive intervention
Meta-regression beta per year of follow-up -0.00 [-0.02, 0.02]
15 studies · 10768 participants
GRADE not reported
Caries Progression Rates Revisited: A Systematic Review. 2019 All outcomesPer additional year of follow-up · Western or comparable populations · Not adjusted
Meta-regression beta per year of follow-up -0.00 [-0.01, 0.01]
15 studies · 10768 participants
GRADE not reported
Circuit lifespana · AKI patients receiving CKRT
1 finding from 1 review
Death from any cause at day 28 of · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recovery of kidney function · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Vascular access complications · AKI patients receiving CKRT
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caries experience (mean DMFT) · 12-year-old children across European countries (national/regional epidemiological surveys, 2011-2022)
Mean DMFT tended to increase with unemployment rate (low 1.23, medium 2.08, high 2.38; ANOVA p<.05); descriptive country-level means only, not meta-analyzed or GRADE-rated.
3 findings from 1 review
Odds of higher caries (DMFT) category · 12-year-old children across European countries (national/regional epidemiological surveys, 2011-2022)
Unemployment rate was not independently associated with DMFT category in the adjusted model (OR 0.99, 95% CI 0.44 to 2.23); not GRADE-rated.
1 finding from 1 review
Reduction in level of contamination in aerosols (CFU per cubic feet/min/patient) using Reyniers slit sampler 30 inches (76 cm) from floor · People undergoing aerosol-generating procedures (AGPs) in a dental setting
It is very uncertain whether laminar air flow with HEPA filter changes reduction in level of contamination in aerosols (CFU per cubic… compared with without laminar flow or filter (very low certainty).
1 finding from 1 review
Reduction in level of contamination in aerosols (CFU per cubic feet/min/patient) using Andersen cascade sampler 20-30 cm from mouth · People undergoing aerosol-generating procedures (AGPs) in a dental setting
It is very uncertain whether laminar air flow with HEPA filter changes reduction in level of contamination in aerosols (CFU per cubic… compared with without laminar flow or filter (very low certainty).
1 finding from 1 review
Overall survival ( · neoadjuvant therapy for early breast cancer
Taxane followed by anthracyclines showed no clear difference in overall survival ( compared with anthracyclines followed by taxane (moderate certainty).
1 finding from 1 review
Grade 3 to 4 neutropenia · adjuvant therapy for early breast cancer
Taxane followed by anthracyclines leads to lower adverse events: neutropenia (grade 3/4) ( compared with anthracyclines followed by taxane (high certainty).
1 finding from 1 review
Adverse events: neurotoxicity (grade 3/4) ( · adjuvant therapy for early breast cancer
Taxane followed by anthracyclines showed no clear difference in adverse events: neurotoxicity (grade 3/4) ( compared with anthracyclines followed by taxane (low certainty).
1 finding from 1 review
Treatment adherence (defined as dose delay) ( · adjuvant therapy for early breast cancer
Taxane followed by anthracyclines showed no clear difference in treatment adherence (defined as dose delay) ( compared with anthracyclines followed by taxane (moderate certainty).
1 finding from 1 review
Quality of life ( · adjuvant therapy for early breast cancer
1 finding from 1 review
Disease-free survival · neoadjuvant therapy for early breast cancer
Taxane followed by anthracyclines showed no clear difference in disease‐free survival ( compared with anthracyclines followed by taxane (moderate certainty).
1 finding from 1 review
Pathological complete response · neoadjuvant therapy for early breast cancer
Taxane followed by anthracyclines showed no clear difference in pathological complete response (no invasive cancer in breast or… compared with anthracyclines followed by taxane (high certainty).
1 finding from 1 review
Grade 3 to 4 neutropenia · neoadjuvant therapy for early breast cancer
Taxane followed by anthracyclines showed no clear difference in adverse events: neutropenia (grade 3/4) ( compared with anthracyclines followed by taxane (moderate certainty).
1 finding from 1 review